A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation
- 1 May 1988
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 251 (3) , 831-842
- https://doi.org/10.1042/bj2510831
Abstract
A heparin-binding protein was isolated from bovine uteri and purified to homogeneity. This protein appears as a double band of approx. 78 kDa in SDS/polyacrylamide-gel electrophoresis and has an isoelectric point of 5.2. The binding of heparin to this protein is saturable. No other glycosaminoglycan from mammalian tissue, such as hyaluronic acid, chondroitin sulphate, dermatan sulphate or keratan sulphate, binds to the 78 kDa protein. Dextran sulphate binds in a non-saturable fashion. Certain heparan sulphate polysaccharide structures are required for binding to the 78 kDa protein. Some proteoheparan sulphates, such as endothelial cell-surface proteoheparan sulphate, show only weak interaction with the 78 kDa protein in contrast with a basement-membrane proteoheparan sulphate from HR-9 cells. Antibodies against the 78 kDa protein inhibit binding of proteoheparan [35S]sulphate from basement membranes to smooth-muscle cells. Conventional antibodies, Fab fragments and some monoclonal antibodies, inhibit smooth-muscle cell proliferation in a similar range as that observed for heparin. The protein was detected in a variety of tissues and cells but not in blood cells. A possible role of this protein as a receptor for heparin or heparan sulphate and its function in the control of the arterial wall structure are discussed.This publication has 37 references indexed in Scilit:
- Isolation and characterization of basement membrane and cell proteoheparan sulphates from HR9 cellsEuropean Journal of Biochemistry, 1986
- HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.The Journal of Immunology, 1986
- In vitro expression of a 38,000 dalton heparin‐binding glycoprotein by morphologically differentiated smooth muscle cellsJournal of Cellular Physiology, 1986
- Mechanisms of cytoskeletal regulation: Modulation of aortic endothelial cell protein band 4.1 by the extracellular matrixJournal of Cellular Physiology, 1986
- Binding and internalization of heparin by vascular smooth muscle cellsJournal of Cellular Physiology, 1985
- An analogue of the erythroid membrane skeletal protein 4.1 in nonerythroid cells.The Journal of cell biology, 1984
- Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.Journal of Biological Chemistry, 1982
- endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins.Proceedings of the National Academy of Sciences, 1982
- Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factor.Proceedings of the National Academy of Sciences, 1981
- Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin.Circulation Research, 1980